Hemangiomas of infants and children have been successfully treated by interferon as salvage therapy after failure of standard surgical, irradiation, or steroid therapy. In this study of 28 infants and children, we have conclusively demonstrated that interferon alfa-2a is a safe, practical, and effective primary therapy for hemangiomas. The treatment appears to remain effective, and in the rare instance of recurrence after treatment was stopped, additional regression can be obtained. These observations provide encouragement for use of interferon alfa-2a as primary therapy for infantile and childhood hemangiomas.
|Translated title of the contribution||High efficacy in the interferon alfa-2a treatment of hemangiomas of newborns and babies: Preliminary results|
|Number of pages||6|
|Journal||Rivista Italiana di Pediatria|
|Publication status||Published - 1997|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health